Why Choose
Wegovy contains semaglutide, a GLP-1 receptor agonist that works by mimicking a natural hormone (glucagon-like peptide-1) in the body. This hormone plays a key role in regulating blood sugar levels, slowing down gastric emptying, and promoting feelings of fullness. By increasing satiety and reducing hunger, Wegovy helps patients reduce overall calorie intake and make healthier food choices.
In addition to appetite control, Wegovy helps improve blood sugar levels and reduces the risk of cardiovascular complications related to excess body weight.
- Clinically proven effectiveness: Helps users lose up to 15-17% of body weight.
- FDA-approved for weight loss: Specifically designed for obesity and overweight management.
- Convenient weekly dosing: Simplifies the treatment process.
- GLP-1 mechanism: Mimics natural hormones to suppress appetite and increase fullness.
- Improved health outcomes: Benefits extend beyond weight loss to improved metabolic and cardiovascular health.
- Well-researched and trusted: Backed by robust clinical trials and real-world success.
Wegovy is an excellent choice for those seeking a targeted, effective, and manageable solution for weight loss, especially if other treatments have not been effective.
Common Uses
Wegovy (semaglutide) is primarily used as a weight loss medication for individuals who are obese or overweight with associated health risks. Its uses extend beyond just weight management, thanks to its effects on appetite control, glucose metabolism, and overall health. Below are the common uses of Wegovy:
Chronic weight management
Wegovy is approved for long-term weight management in adults who meet specific criteria:
- Obesity: For individuals with a Body Mass Index (BMI) of 30 or higher.
- Overweight with Comorbidities: For individuals with a BMI of 27 or higher who also have at least one weight-related condition, such as:
- Type 2 diabetes.
- High blood pressure (hypertension).
- High cholesterol (dyslipidemia).
- Obstructive sleep apnea.
Wegovy is most effective when combined with a comprehensive weight management program, including:
- A reduced-calorie diet.
- Increased physical activity.
- Behavioral therapy for long-term lifestyle changes.
Reduction of obesity-related health risks
By helping individuals achieve significant weight loss, Wegovy reduces the risk or severity of health conditions associated with obesity, such as:
- Cardiovascular diseases: Includes heart disease, stroke, and heart failure.
- Hypertension: Weight loss can lower blood pressure, reducing the strain on the cardiovascular system.
- Dyslipidemia: Wegovy helps improve cholesterol levels, reducing LDL (bad cholesterol) and increasing HDL (good cholesterol).
- Type 2 diabetes prevention: For individuals with prediabetes, Wegovy reduces the likelihood of progressing to type 2 diabetes by improving insulin sensitivity and promoting weight loss.
Support for individuals with type 2 diabetes
Although Wegovy is not primarily approved for type 2 diabetes treatment, it has significant benefits for individuals with both obesity and diabetes:
- Improved blood sugar control: Wegovy mimics GLP-1, a hormone that stimulates insulin secretion and reduces glucose production, leading to better glycemic control.
- Reduced insulin resistance: By reducing body weight and fat mass, Wegovy helps improve insulin sensitivity, making it easier for the body to use glucose efficiently.
Improving quality of life
Weight loss achieved with Wegovy can lead to:
- Increased energy levels.
- Better mobility and reduced joint pain, especially for those with conditions like osteoarthritis.
- Enhanced mental health and self-esteem as individuals experience improvements in their physical health and appearance.
How It Works
Wegovy contains semaglutide, a GLP-1 receptor agonist that works by mimicking a natural hormone (glucagon-like peptide-1) in the body. This hormone plays a key role in regulating blood sugar levels, slowing down gastric emptying, and promoting feelings of fullness. By increasing satiety and reducing hunger, Wegovy helps patients reduce overall calorie intake and make healthier food choices.
Wegovy works by:
- Suppressing appetite, reducing the desire to overeat.
- Increasing feelings of fullness (satiety), helping individuals eat smaller portions and consume fewer calories overall. This makes it particularly useful for individuals struggling with portion control or food cravings.
In addition to appetite control, Wegovy helps improve blood sugar levels and reduces the risk of cardiovascular complications related to excess body weight.
How to use:
- Injection: Wegovy is administered once a week via a simple subcutaneous (under the skin) injection. It can be injected in the thigh, abdomen, or upper arm.
- Gradual dose adjustment: The dosage starts at 0.25mg for the first four weeks, gradually increasing to 0.5mgand then to 1.0mg, as recommended by your healthcare provider.
- Consistency: For optimal results, it is important to use Wegovy consistently, along with a reduced-calorie diet and increased physical activity, to support healthy weight loss.
